KPV (Lys-Pro-Val) is a naturally occurring three-amino-acid fragment of α-melanocyte-stimulating hormone (α-MSH). Despite its small size, it retains much of the parent hormone’s anti-inflammatory activity while lacking the pigmentation effects associated with full-length α-MSH.

Unlike many immune-modulating peptides, KPV appears to regulate inflammatory signalling without broadly suppressing immune function. This has made it one of the most interesting investigational peptides for research involving inflammatory diseases, epithelial barrier function and mucosal immunity.

Why KPV is widely investigated

Published research has investigated KPV in relation to:

immune regulation
inflammatory signalling
gut health research
intestinal barrier function
skin inflammation
epithelial biology
wound healing
mucosal immunity
NF-κB signalling

Because of its small size and unique mechanism, KPV has become one of the best-known research peptides targeting inflammatory pathways rather than structural tissue repair.

How KPV works

Unlike BPC-157 or TB-500, KPV is primarily investigated for its effects on immune signalling rather than tissue regeneration.

Published research has explored its relationship with:

Inflammatory signalling

KPV has been widely investigated for its ability to reduce activation of inflammatory pathways including NF-κB, resulting in lower production of multiple pro-inflammatory mediators in experimental models.

Gut barrier research

One of the largest areas of investigation focuses on intestinal epithelial cells and experimental models of inflammatory bowel disease, where KPV has demonstrated effects on epithelial integrity and inflammatory signalling.

Skin biology

Researchers have also explored KPV in models of inflammatory skin conditions and wound repair because of its effects on epithelial tissues.

Immune modulation

Current evidence suggests that KPV modulates immune responses rather than producing broad immunosuppression, making it an interesting candidate for studies of physiological inflammatory regulation.

Why KPV is becoming increasingly important

Interest in KPV has increased significantly over the last several years because it represents a different approach to inflammation research.

Rather than focusing primarily on structural tissue repair like BPC-157 or systemic regeneration like TB-500, KPV investigates the signalling pathways that initiate and maintain inflammation.

This complementary biology has made KPV increasingly popular in research involving inflammatory bowel disease, skin biology and epithelial barrier function.

Human and preclinical research

Most published evidence for KPV comes from cell culture and animal models.

Research has consistently investigated inflammatory signalling in the gut, skin, lungs and epithelial tissues, while human clinical evidence remains limited. Although the preclinical data are encouraging, additional human research is required before conclusions can be drawn regarding clinical applications.

Published safety observations

Current knowledge of KPV is derived predominantly from laboratory and preclinical research. Published studies generally report favourable tolerability in experimental models, but controlled human clinical evidence remains limited. As with many emerging research peptides, additional studies are needed to fully characterise long-term efficacy and safety.

Product characteristics

Application: laboratory and analytical research
Use restriction: not for human consumption; not for medical, veterinary or cosmetic use
Produced in GMP-compliant facilities under strict QC protocols.
Each batch carefully lab tested after production (you can find Certificate of Analysis under product pictures).
Freeze-dried (lyophilized) for maximum stability and extended shelf life.
Sealed in sterile vials, ready for reconstitution.
Purity: ≥99% (HPLC-tested)
Appearance: Lyophilized white/off-white powder
Molecular formula: C₁₆H₃₀N₄O₄
Molecular weight: 342.43
Sequence: Lys-Pro-Val
Storage: unopened lyophilized vials are best stored refrigerated at 2–8°C, which is the storage method confirmed by our manufacturing partner and suitable for up to 24 months. Refrigeration is preferred because it minimizes unnecessary freeze–thaw cycles during routine handling. If substantially longer-term storage is required, unopened lyophilized vials may also be kept frozen. Once reconstituted, always store at 2–8°C and do not freeze.

Reconstitution and handling

KPV is supplied as a lyophilised vial and should be handled using standard peptide reconstitution procedures appropriate to the research setting. Must be reconstituted with bacteriostatic water before use. To help preserve structural integrity, add the chosen solvent slowly against the inside wall of the vial rather than directly onto the peptide cake, and avoid vigorous shaking. Gentle swirling is generally sufficient once the peptide has fully dissolved. Standard laboratory practice also includes allowing refrigerated vials to reach room temperature before reconstitution to minimise condensation inside the vial.

For other solvent selection, concentration planning and storage guidance, see the full Peptide Reconstitution Guide and Reconstitution Calculator.

Selected research references

Dalmasso G, et al. PepT1-Mediated Uptake of the Tripeptide KPV Reduces Intestinal Inflammation, Molecular Therapy, 2011

A landmark study demonstrating epithelial uptake of KPV and reduced inflammatory signalling in experimental intestinal inflammation.

Kannengiesser K, et al. KPV Protects Against Experimental Colitis Through Modulation of Inflammatory Pathways, Gastroenterology Research, 2017

Research demonstrating protective effects of KPV in experimental inflammatory bowel disease models.

Brzoska T, Luger TA, et al. Alpha-MSH and the C-Terminal Tripeptide KPV in Inflammation, Journal of Investigative Dermatology, 2003

A foundational review explaining why the KPV fragment retains potent anti-inflammatory activity despite lacking the full α-MSH sequence.

Merlin D, et al. KPV and Epithelial Immune Regulation, Various publications

A series of studies exploring KPV transport through PepT1 and regulation of epithelial inflammatory signalling.

Frequently Asked Questions

What is KPV?

KPV is a naturally occurring tripeptide derived from α-melanocyte-stimulating hormone (α-MSH). It is widely investigated for immune regulation, inflammatory signalling and epithelial barrier research.

Why is KPV different from BPC-157?

Although both peptides are frequently discussed in recovery research, BPC-157 is primarily investigated for tissue repair, whereas KPV focuses on immune regulation and inflammatory signalling. Their biological targets are complementary rather than identical.

Why is KPV associated with gut health research?

Much of the published literature has investigated KPV in intestinal epithelial cells and experimental models of inflammatory bowel disease because of its effects on inflammatory signalling and epithelial barrier function.

What research areas commonly investigate KPV?

Current research includes immune regulation, gut inflammation, epithelial biology, wound healing, skin inflammation, mucosal immunity and inflammatory signalling.

Does KPV work through melanocortin receptors?

Current evidence suggests that many of KPV’s anti-inflammatory effects occur independently of classical melanocortin receptor signalling, making it mechanistically distinct from full-length α-MSH.

Is this product intended for human use?

No. KPV supplied by LIFE Peptide is provided strictly for laboratory and analytical research. It is not intended for human consumption, diagnosis, treatment or prevention of disease. Any discussion of published studies summarises the scientific literature relating to the KPV molecule rather than the intended use of this product.

Related research context

KPV belongs to the Healing & recovery peptide research category, with a stronger focus on inflammatory signaling and epithelial pathway investigation. KPV is frequently discussed alongside other research peptides investigating immune regulation, tissue repair and recovery:

BPC-157 – investigated primarily for tissue repair, tendon biology and angiogenesis.
TB-500 (Thymosin β4) – studied for cell migration, regeneration and wound healing.
Glow Blend – combines GHK-Cu, BPC-157 and TB-500 for multi-pathway recovery research.
Wolverine Blend – combines BPC-157 and TB-500 for connective tissue and regeneration studies.
GHK-Cu – investigated in skin biology, extracellular matrix remodelling and wound repair.

Although these peptides are often grouped within recovery research, KPV stands apart by focusing primarily on immune regulation and inflammatory signalling rather than structural tissue regeneration.
For broader context, see the Healing & recovery research guide.

NOTE: This is for educational reference only and does not constitute medical advice.

Disclaimer:
This product is sold for research purposes only. It is not intended to diagnose, treat, cure, or prevent any disease. Buyer assumes full responsibility for proper handling and use.

Epithelbarriere

KPV 5 mg